Skeletal progenitors and the GNAS gene: fibrous dysplasia of bone read through stem cells
- 14 September 2010
- journal article
- review article
- Published by Bioscientifica in Journal of Molecular Endocrinology
- Vol. 45 (6), 355-364
- https://doi.org/10.1677/jme-10-0097
Abstract
Activating mutations of the GNAS gene, which causes fibrous dysplasia of bone (FD), lead to remarkable changes in the properties of skeletal progenitors, and it is these changes that mediate the pathological effect of this gene on bone. Mutated skeletal stem cells lose the ability to differentiate into adipocytes, and to maintain in situ, and transfer heterotopically, the hematopoietic microenvironment, leading to abnormal bone marrow histology in FD. They overexpress molecular effectors of osteoclastogenesis, thus promoting inappropriate bone resorption leading to fragility of FD bone. They express the phosphate-regulating hormone FGF-23 at normal levels, whose excess in the serum of FD patients correlates with the mass of osteogenic cells within FD lesions, leading to osteomalacia and deformity of the FD bone, and revealing that bone is an endocrine organ regulating renal handling of phosphate. Mechanisms of allelic selection and stem cell selection occur in mutated skeletal stem cells and contribute to the inherent diversity and evolution over time in FD. The definition of the etiological role of GNAS mutations marks the watershed between many decades of descriptive observation and the definition of cellular and molecular mechanisms that would explain and hopefully allow for a cure for the disease. Placing stem cells at center stage has permitted substantial advances in one decade, and promises more for the one to come.Keywords
This publication has 65 references indexed in Scilit:
- Age-Dependent Demise of GNAS-Mutated Skeletal Stem Cells and “Normalization” of Fibrous Dysplasia of BoneJournal of Bone and Mineral Research, 2008
- Mesenchymal Stem Cells: Revisiting History, Concepts, and AssaysCell Stem Cell, 2008
- GNAS transcripts in skeletal progenitors: evidence for random asymmetric allelic expression of GsHuman Molecular Genetics, 2007
- Fibrous Dysplasia as a Stem Cell DiseaseJournal of Bone and Mineral Research, 2006
- Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolismNature Genetics, 2006
- Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasiaLife Sciences, 2006
- Quantification of G Protein Gαs Subunit Splice Variants in Different Human Tissues and Cells Using PyrosequencingGene Expression, 2005
- Osteomalacic and Hyperparathyroid Changes in Fibrous Dysplasia Of Bone: Core Biopsy Studies and Clinical CorrelationsJournal of Bone and Mineral Research, 2003
- Paternal imprinting of Gαs in the human thyroid as the basis of TSH resistance in pseudohypoparathyroidism type 1aBiochemical and Biophysical Research Communications, 2002
- Characterization of the Extra-large G Protein α-Subunit XLαsOnline Journal of Public Health Informatics, 2000